Epilepsy Trial, Recruiting (NCT05864547)

Epilepsy Trial, Recruiting NCT05864547 Sponsor: Norwegian University of Science and Technology Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT05864547 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are having your first-ever stroke and are being treated at the stroke unit at St. Olavs Hospital
Before this stroke, you were largely independent in daily life with little to no disability (confirm with trial site)
You are able to understand and agree to take part in the trial yourself

Who may not be able to join:

You have had a stroke or brain surgery before
You have had a traumatic brain injury (such as a serious head injury)
You have a condition where the brain gradually stops working properly over time, such as Parkinson's disease or dementia
You have a brain tumour
You had epilepsy (seizures) before this stroke
You have a condition where fluid builds up in the brain (hydrocephalus)
You have difficulty speaking, understanding, reading, or writing as a pre-existing condition (aphasia)
You have a serious mental health condition
You are unable to have an MRI scan for medical reasons, or you experience severe anxiety in enclosed spaces (claustrophobia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Axel Sandvig, PhD prof, Norwegian Science and Technology University

Phone: +47 47333042

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05864547

Sponsor: Norwegian University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: +47 47333042

More information: https://clinicaltrials.gov/study/NCT05864547

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are having your first-ever stroke and are being treated at the stroke unit at St. Olavs Hospital
Before this stroke, you were largely independent in daily life with little to no disability (confirm with trial site)
You are able to understand and agree to take part in the trial yourself

Who may not be able to join:

You have had a stroke or brain surgery before
You have had a traumatic brain injury (such as a serious head injury)
You have a condition where the brain gradually stops working properly over time, such as Parkinson's disease or dementia
You have a brain tumour
You had epilepsy (seizures) before this stroke
You have a condition where fluid builds up in the brain (hydrocephalus)
You have difficulty speaking, understanding, reading, or writing as a pre-existing condition (aphasia)
You have a serious mental health condition
You are unable to have an MRI scan for medical reasons, or you experience severe anxiety in enclosed spaces (claustrophobia)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Norwegian University of Science and Technology

Registry

ClinicalTrials.gov

Start date

8 May 2023

Est. completion

1 December 2030

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Post-stroke epilepsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov